GINA asthma strategy: what’s new for 2020?

2020-07-22T15:01:00+01:00By Dr Mark L Levy

Dr Mark L Levy highlights updated recommendations on asthma therapy from the 2020 Global Initiative for Asthma (GINA) report and signposts resources for online learning

Coronavirus visualisation blue

COVID-19 respiratory guidelines: implications for primary care

2020-06-18T12:34:00+01:00By Dr Kevin Gruffydd-Jones

Dr Kevin Gruffydd-Jones highlights common themes and important considerations from NICE COVID-19 rapid guidelines on severe asthma, pneumonia, and COPD

Respiratory tract visualisation resized_AS

Key learning points: malnutrition in people with COPD


Dr Anita Nathan identifies key learning points for primary care from a best-practice guide to managing malnutrition in COPD

A 3D CT scan of lungs affected by emphysema

Key learning points: GOLD COPD 2020 report

2020-03-20T10:03:00+00:00By Professor David Halpin

Professor David Halpin highlights key learnings for primary care from the updated GOLD strategy for chronic obstructive pulmonary disease

Coronavirus visualisation

Coronavirus: what is the role of primary care?


Dr Toni Hazell summarises the recent guidance on how to identify possible cases of novel coronavirus and why suspected cases must be isolated immediately

Educational resources

Final version - Soprobec supplement

Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice. Please see bottom of page for full disclaimer.

ICS consensus

How should inhaled steroids be used in the management of asthma in adults within a primary care setting?

Supported by an educational grant from CIPLA EU Ltd

Information intended for healthcare professionals only.

Index picture

Respimat® Soft Mist™ reusable inhaler: patient benefits and environmental impact

Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice. Boehringer Ingelheim Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the ...

GiP Front page

The re-usable Respimat® Soft Mist™ inhaler

Commissioned by Boehringer Ingelheim Limited

Information for healthcare professionals only.